NCT00003427View on ClinicalTrials.gov

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 30, 1998

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Anal CancerColorectal CancerEsophageal CancerExtrahepatic Bile Duct CancerGallbladder CancerGastric CancerGastrointestinal Carcinoid TumorLiver CancerPancreatic CancerSmall Intestine Cancer
Interventions
DRUG

irinotecan hydrochloride

DRUG

oxaliplatin

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003427 - Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer | Biotech Hunter | Biotech Hunter